BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17686479)

  • 1. RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.
    Badawy A; Mosbah A; Shady M
    Fertil Steril; 2008 May; 89(5):1209-1212. PubMed ID: 17686479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial.
    Badawy A; Abdel Aal I; Abulatta M
    Fertil Steril; 2009 Sep; 92(3):849-852. PubMed ID: 17582406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED: Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.
    Abu Hashim H; Shokeir T; Badawy A
    Fertil Steril; 2010 Sep; 94(4):1405-1409. PubMed ID: 19732888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTED: Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial.
    Badawy A; Elnashar A; Totongy M
    Fertil Steril; 2009 Oct; 92(4):1355-1359. PubMed ID: 18692823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
    Franik S; Eltrop SM; Kremer JA; Kiesel L; Farquhar C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010287. PubMed ID: 29797697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial.
    Badawy A; Abdel Aal I; Abulatta M
    Fertil Steril; 2009 Sep; 92(3):860-863. PubMed ID: 18166179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.
    Kamath MS; George K
    Reprod Biol Endocrinol; 2011 Jun; 9():86. PubMed ID: 21693034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome.
    Hajishafiha M; Dehghan M; Kiarang N; Sadegh-Asadi N; Shayegh SN; Ghasemi-Rad M
    Drug Des Devel Ther; 2013; 7():1427-31. PubMed ID: 24348019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome.
    Banerjee Ray P; Ray A; Chakraborti PS
    Arch Gynecol Obstet; 2012 Mar; 285(3):873-7. PubMed ID: 21984038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole versus clomiphene citrate: which is better for ovulation induction?
    Casper RF
    Fertil Steril; 2009 Sep; 92(3):858-859. PubMed ID: 17588568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.
    Begum MR; Ferdous J; Begum A; Quadir E
    Fertil Steril; 2009 Sep; 92(3):853-857. PubMed ID: 18177867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
    Bjelica A; Trninić-Pjević A; Mladenović-Segedi L; Cetković N; Petrović D
    Srp Arh Celok Lek; 2016; 144(3-4):146-50. PubMed ID: 27483558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.
    Kamath MS; Aleyamma TK; Chandy A; George K
    Fertil Steril; 2010 Dec; 94(7):2857-9. PubMed ID: 20638059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.
    Amer SA; Smith J; Mahran A; Fox P; Fakis A
    Hum Reprod; 2017 Aug; 32(8):1631-1638. PubMed ID: 28854590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.
    Abdellah MS
    Int J Gynaecol Obstet; 2011 Jun; 113(3):218-21. PubMed ID: 21457973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome.
    Zeinalzadeh M; Basirat Z; Esmailpour M
    J Reprod Med; 2010; 55(1-2):36-40. PubMed ID: 20337206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial.
    Ibrahim MI; Moustafa RA; Abdel-Azeem AA
    Arch Gynecol Obstet; 2012 Dec; 286(6):1581-7. PubMed ID: 22829102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.
    Legro RS; Kunselman AR; Brzyski RG; Casson PR; Diamond MP; Schlaff WD; Christman GM; Coutifaris C; Taylor HS; Eisenberg E; Santoro N; Zhang H;
    Contemp Clin Trials; 2012 May; 33(3):470-81. PubMed ID: 22265923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.